An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer's disease and neurodegeneration

Chemico-Biological Interactions

Volumn 226, Issue , 2015, Pages 30-39

  Pike, Adrianne F ^a   Kramer, Nynke I ^b   Blaauboer, Bas J ^b   Seinen, Willem ^a,b   Brands, Ruud ^a,b  

^a AMRIF BV   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alkaline phosphatase; Alzheimers disease; Blood brain barrier; Neurodegenerative diseases; Neuroinflammation; RESCAP

Indexed keywords

ALKALINE PHOSPHATASE;

ALZHEIMER DISEASE; ANIMAL; ANTIBODY SPECIFICITY; COMPLICATION; ENZYMOLOGY; HUMAN; INFLAMMATION; METABOLISM; PROTEIN TRANSPORT;

ALKALINE PHOSPHATASE; ALZHEIMER DISEASE; ANIMALS; HUMANS; INFLAMMATION; ORGAN SPECIFICITY; PROTEIN TRANSPORT;

EID: 84925344746     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.12.006     Document Type: Review

References (128)

1. W. Schulte, J. Bernhagen, R. Bucala Cytokines in sepsis: potent immunoregulators and potential therapeutic targets - an updated view Mediators Inflamm. 2013 2013 165974 10.1155/2013/165974
2. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
3. L. Senovilla, L. Galluzzi, L. Zitvogel, G. Kroemer Immunosurveillance as a regulator of tissue homeostasis Trends Immunol. 34 2013 471 481
4. M. Morris, L. Li Molecular mechanisms and pathological consequences of endotoxin tolerance and priming Arch. Immunol. Ther. Exp. (Warsz.) 60 2012 13 18
5. A.F. Pike, N.I. Kramer, B.J. Blaauboer, W. Seinen, R. Brands A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response Biochim. Biophys. Acta 2013 1832 2044 2056
6. H. Zimmermann, M. Zebisch, N. Sträter Cellular function and molecular structure of ecto-nucleotidases Purinergic Signal. 8 2012 437 502
7. A. Tuin, A. Huizinga-Van Der Vlag, A.-M.A. Van Loenen-Weemaes, D.K.F. Meijer, K. Poelstra On the role and fate of LPS-dephosphorylating activity in the rat liver Am. J. Physiol. 290 2006 G377 G385
8. S. Kats, R. Brands, M.A.S. Hamad, W. Seinen, V. Scharnhorst, R.W. Wulkan, J.P. Schönberger, W. van Oeveren Prophylactic treatment with alkaline phosphatase in cardiac surgery induces endogenous alkaline phosphatase release Int. J. Artif. Organs 35 2012 144 151
9. K. Poelstra, W.W. Bakker, P.A. Klok, J.A.A.M. Kamps, M.J. Hardonk, D.K.F. Meijer Dephosphorylation of endotoxin by alkaline phosphatase in vivo Am. J. Pathol. 151 1997 1163 1169
10. H. Bentala, W.R. Verweij, A. Huizinga-Van Der Vlag, A.M. Van Loenen-Weemaes, D.K.F. Meijer, K. Poelstra Removal of phosphate from lipid a as a strategy to detoxify lipopolysaccharide Shock 18 2002 561 566
11. K. Kaliannan, S.R. Hamarneh, K.P. Economopoulos, S.N. Alam, O. Moaven, P. Patel, N.S. Malo, M. Ray, S.M. Abtahi, N. Muhammad, A. Raychowdhury, A. Teshager, M.M. Rafat Mohamed, A.K. Moss, R. Ahmed, S. Hakimian, S. Narisawa, J.L. Millán, E. Hohmann, H.S. Warren, A.K. Bhan, M.S. Malo, R.A. Hodin Intestinal alkaline phosphatase prevents metabolic syndrome in mice Proc. Natl. Acad. Sci. U.S.A. 110 2013 7003 7008
12. K.M. Riggle, R.M. Rentea, S.R. Welak, K.A. Pritchard Jr., K.T. Oldham, D.M. Gourlay Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis J. Surg. Res. 180 2013 21 26
13. R.C. De Lisle, R. Mueller, M. Boyd Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse J. Pediatr. Gastroenterol. Nutr. 53 2011 371 379
14. P. Pickkers, S. Heemskerk, J. Schouten, P. Laterre, J. Vincent, A. Beishuizen, P.G. Jorens, H. Spapen, M. Bulitta, W.H.M. Peters, J.G. van der Hoeven Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial Crit. Care 16 1 2012 (article number R14)
15. U. Beuers, S. Hohenester, L.J. de Buy Wenniger, A.E. Kremer, P.L. Jansen, R.P. Elferink The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies Hepatology 52 2010 1489 1496
16. M. Mizumori, M. Ham, P.H. Guth, E. Engel, J.D. Kaunitz, Y. Akiba Intestinal alkaline phosphatase regulates protective surface microclimate pH in rat duodenum J. Physiol. (Lond.) 587 2009 3651 3663
17. J.M. Banales, J. Prieto, J.F. Medina Cholangiocyte anion exchange and biliary bicarbonate excretion World J. Gastroenterol. 12 2006 3496 3511
18. M. Picher, L.H. Burch, A.J. Hirsh, J. Spychala, R.C. Boucher Ecto 5′-nucleotidase and nonspecific alkaline phosphatase: two AMP-hydrolyzing ectoenzymes with distinct roles in human airways J. Biol. Chem. 278 2003 13468 13479
19. E. Blom, M.M. Ali, B. Mortensen, N. Huseby Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates Clin. Chim. Acta 270 1998 125 137
20. K. Ritter, A. Fudickar, N. Heine, R. Thomssen Autoantibodies with a protective function: polyreactive antibodies against alkaline phosphatase in bacterial infections Med. Microbiol. Immunol. (Berl.) 186 1997 109 113
21. R.S. Blumberg, T. Koss, C.M. Story, D. Barisani, J. Polischuk, A. Lipin, L. Pablo, R. Green, N.E. Simister A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes J. Clin. Invest. 95 1995 2397 2402
22. M. Mäder, N. Kolbus, D. Meihorst, A. Köhn, W. Beuche, K. Felgenhauer Human intestinal alkaline phosphatase-binding IgG in patients with severe bacterial infections Clin. Exp. Immunol. 95 1994 98 102
23. P.M. Crofton, D.C. Kilpatrick, A.G. Leitch Complexes in serum between alkaline phosphatase and immunoglobulin G: immunological and clinical aspects Clin. Chim. Acta 111 1981 257 265
24. P.M. Crofton Site of alkaline phosphatase attachment in alkaline phosphatase-immunoglobulin G complexes Clin. Chim. Acta 112 1981 33 42
25. J.B. Burgess, J.U. Baenziger, W.R. Brown Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis Hepatology 15 1992 702 706
26. A. Rayah, J.M. Kanellopoulos, F. Di Virgilio P2 receptors and immunity Microb. Infect. 14 2012 1254 1262
27. A.P. Feranchak, M.A. Lewis, C. Kresge, M. Sathe, A. Bugde, K. Luby-Phelps, P.P. Antich, J.G. Fitz Initiation of purinergic signaling by exocytosis of ATP-containing vesicles in liver epithelium J. Biol. Chem. 285 2010 8138 8147
28. P.H. Weigel, J.H.N. Yik Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors Biochim. Biophys. Acta 1572 2002 341 363
29. J.L. Millán Alkaline phosphatases Purinergic Signal. 2 2006 335 341
30. L.D. Gaspers, E. Mémin, A.P. Thomas Calcium-dependent physiologic and pathologic stimulus-metabolic response coupling in hepatocytes Cell Calcium 52 2012 93 102
31. F. Luton, M.J. Hexham, M. Zhang, K.E. Mostov Identification of a cytoplasmic signal for apical transcytosis Traffic 10 2009 1128 1142
32. J. Nagata, M.T. Guerra, C.A. Shugrue, D.A. Gomes, N. Nagata, M.H. Nathanson Lipid rafts establish calcium waves in hepatocytes Gastroenterology 133 2007 256 267
33. C.K. Glass, K. Saijo, B. Winner, M.C. Marchetto, F.H. Gage Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934
34. A. von Mikecz Pathology and function of nuclear amyloid: protein homeostasis matters Nucleus 5 2014 311 317
35. B. Wang, K. Jin Current perspectives on the link between neuroinflammation and neurogenesis Metab. Brain Dis. 2014 1 11
36. D. Doens, P.L. Fernández Microglia receptors and their implications in the response to amyloid ß for Alzheimer's disease pathogenesis J. Neuroinflamm. 11 2014 48
37. K.I. Mosher, T. Wyss-Coray Microglial dysfunction in brain aging and Alzheimer's disease Biochem. Pharmacol. 88 2014 594 604
38. S.E. Lesné, M.A. Sherman, M. Grant, M. Kuskowski, J.A. Schneider, D.A. Bennett, K.H. Ashe Brain amyloid-ß oligomers in ageing and Alzheimer's disease Brain 136 2013 1383 1398
39. T. Wyss-Coray Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12 2006 1005 1015
40. A.M. Blokhuis, E.J.N. Groen, M. Koppers, L.H. Van Den Berg, R.J. Pasterkamp Protein aggregation in amyotrophic lateral sclerosis Acta Neuropathol. 125 2013 777 794
41. S.E. Eisbach, T.F. Outeiro Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology J. Mol. Med. 91 2013 693 703
42. S. Engelender Ubiquitination of a-synuclein and autophagy in Parkinson's disease Autophagy 4 2008 372 374
43. K. Arima, S. Hirai, N. Sunohara, K. Aoto, Y. Izumiyama, K. Uéda, K. Ikeda, M. Kawai Cellular co-localization of phosphorylated tau- and NACP/a-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies Brain Res. 843 1999 53 61
44. T. Ishizawa, P. Mattila, P. Davies, D. Wang, D.W. Dickson Colocalization of tau and alpha-synuclein epitopes in Lewy bodies J. Neuropathol. Exp. Neurol. 62 2003 389 397
45. M.L. Schmidt, J.A. Martin, V.M. Lee, J.Q. Trojanowski Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders Acta Neuropathol. 91 1996 475 481
46. X. Bi, J. Liu, Y. Yao, M. Baudry, G. Lynch Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain Am. J. Pathol. 167 2005 1081 1092
47. B.L. Fiebich, S. Akter, R.S. Akundi The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain Front. Cell. Neurosci. 8 2014 260 10.3389/fncel.2014.00260
48. C. Holmes Review: systemic inflammation and Alzheimer's disease Neuropathol. Appl. Neurobiol. 39 2013 51 68
49. T.L. Spires-Jones, B. Hyman The intersection of amyloid beta and tau at synapses in Alzheimer's disease Neuron 82 2014 756 771
50. M.E. Larson, M.A. Sherman, S. Greimel, M. Kuskowski, J.A. Schneider, D.A. Bennett, S.E. Lesné Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology J. Neurosci. 32 2012 10253 10266
51. J.A. Steiner, E. Angot, P. Brundin A deadly spread: cellular mechanisms of a-synuclein transfer Cell Death Differ. 18 2011 1425 1433
52. J.W. Wu, M. Herman, L. Liu, S. Simoes, C.M. Acker, H. Figueroa, J.I. Steinberg, M. Margittai, R. Kayed, C. Zurzolo, G. Di Paolo, K.E. Duff Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons J. Biol. Chem. 288 2013 1856 1870
53. C.M. Lema Tomé, T. Tyson, N.L. Rey, S. Grathwohl, M. Britschgi, P. Brundin Inflammation and a-synuclein's prion-like behavior in Parkinson's disease - is there a link? Mol. Neurobiol. 47 2013 561 574
54. V.H. Perry, C. Cunningham, C. Holmes Systemic infections and inflammation affect chronic neurodegeneration Nat. Rev. Immunol. 7 2007 161 167
55. S. Takeda, N. Sato, R. Morishita Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy Front. Aging Neurosci. 6 2014 171 10.3389/fnagi.2014.00171
56. R. Shrestha, O. Millington, J. Brewer, T. Bushell Lymphocytes protect cortical neurons against excitotoxicity mediated by kainic acid, an in vitro model for neurodegeneration Kathmandu Univ. Med. J. 11 2013 132 138
57. B. Engelhardt, C. Coisne Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle Fluids Barriers CNS 8 1 2011 4 10.1186/2045-8118-8-4
58. R. Cabezas, M. Ávila, J. Gonzalez, R.S. El-Bachá, E. Báez, L.M. García-Segura, J.C.J. Coronel, F. Capani, G.P. Cardona-Gomez, G.E. Barreto Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease Front. Cell. Neurosci. 8 2014 211 10.3389/fncel.2014.00211
59. S. Takeda, N. Sato, K. Ikimura, H. Nishino, H. Rakugi, R. Morishita Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model Neurobiol. Aging 34 2013 2064 2070
60. C. Holmes, J. Butchart Systemic inflammation and Alzheimer's disease Biochem. Soc. Trans. 39 2011 898 901
61. W.J. Streit Microglia and the response to brain injury Ernst Schering Res. Found. Workshop 2002 11 24
62. A.C.C. da Fonseca, D. Matias, C. Garcia, R. Amaral, L.H. Geraldo, C. Freitas, F.R.S. Lima The impact of microglial activation on blood-brain barrier in brain diseases Front. Cell. Neurosci. 8 2014 1 13
63. R.J. Castellani, G. Perry The complexities of the pathology-pathogenesis relationship in Alzheimer disease Biochem. Pharmacol. 88 2014 671 676
64. A. Serrano-Pozo, J. Qian, S.E. Monsell, M.P. Frosch, R.A. Betensky, B.T. Hyman Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the national Alzheimer coordinating center J. Neuropathol. Exp. Neurol. 72 2013 1182 1192
65. C.H. Latta, H.M. Brothers, D.M. Wilcock Neuroinflammation in Alzheimer's disease; a source of heterogeneity and target for personalized therapy Neuroscience 2014 10.1016/j.neuroscience.2014.09.061
66. L.M. Ittner, Y.D. Ke, F. Delerue, M. Bi, A. Gladbach, J. van Eersel, H. Wölfing, B.C. Chieng, M.J. Christie, I.A. Napier, A. Eckert, M. Staufenbiel, E. Hardeman, J. Götz Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models Cell 142 2010 387 397
67. R. Dixit, J.L. Ross, Y.E. Goldman, E.L.F. Holzbaur Differential regulation of dynein and kinesin motor proteins by tau Science 319 2008 1086 1089
68. R.E. Catalán, A.M. Martínez, M.D. Aragonés, B.G. Miguel, A. Robles Insulin action on brain microvessels; effect on alkaline phosphatase Biochem. Biophys. Res. Commun. 150 1988 583 590
69. C. Fonta, L. Négyessy, L. Renaud, P. Barone Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission Cereb. Cortex 14 2004 595 609
70. M. Díaz-Hernández, A. Gómez-Ramos, A. Rubio, R. Gómez-Villafuertes, J.R. Naranjo, M. Teresa Miras-Portugal, J. Avila Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau J. Biol. Chem. 285 2010 32539 32548
71. I. Brun-Heath, M. Ermonval, E. Chabrol, J. Xiao, M. Palkovits, R. Lyck, F. Miller, P. Couraud, E. Mornet, C. Fonta Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues Cell Tissue Res. 343 2011 521 536
72. L. Négyessy, J. Xiao, O. Kántor, G.G. Kovács, M. Palkovits, T.P. Dóczi, L. Renaud, G. Baksa, T. Glasz, M. Ashaber, P. Barone, C. Fonta Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex Neuroscience 172 2011 406 418
73. B. Deracinois, S. Duban-Deweer, G. Pottiez, R. Cecchelli, Y. Karamanos, C. Flahaut TNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties PLoS ONE 7 10 2012 e48428 10.1371/journal.pone.0048428
74. M. Lynes, S. Narisawa, J.L. Millán, E.P. Widmaier Interactions between cd36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet Am. J. Physiol. 301 2011 1738 1747
75. M. Ho, H.L. Hoang, K.M. Lee, N. Liu, T. MacRae, L. Montes, C.L. Flatt, B.G. Yipp, B.J. Berger, S. Looareesuwan, S.M. Robbins Ectophosphorylation of CD36 regulates cytoadherence of Plasmodium falciparum to microvascular endothelium under flow conditions Infect. Immun. 73 2005 8179 8187
76. R.W. Mitchell, N.H. On, M.R. Del Bigio, D.W. Miller, G.M. Hatch Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells J. Neurochem. 117 2011 735 746
77. C. Calhau, F. Martel, S. Pinheiro-Silva, H. Pinheiro, P. Soares-da-Silva, C. Hipólito-Reis, I. Azevedo Modulation of insulin transport in rat brain microvessel endothelial cells by an ecto-phosphatase activity J. Cell. Biochem. 84 2001 389 400
78. C. Calhau, C. Hipólito-Reis, I. Azedvedo Alkaline phosphatase and exchange surfaces Clin. Biochem. 32 1999 153 154
79. R. Ghasemi, A. Haeri, L. Dargahi, Z. Mohamed, A. Ahmadiani Insulin in the brain: sources, localization and functions Mol. Neurobiol. 47 2013 145 171
80. T. Nishijima, J. Piriz, S. Duflot, A.M. Fernandez, G. Gaitan, U. Gomez-Pinedo, J.M.G. Verdugo, F. Leroy, H. Soya, A. Nuñez, I. Torres-Aleman Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS Neuron 67 2010 834 846
81. P.D.K. Lee, A. Suwanichkul, L.A. DePaolis, M.B. Snuggs, S.L. Morris, D.R. Powell Insulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor Regul. Pept. 48 1993 199 206
82. E. Carro, I. Torres-Aleman The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease Eur. J. Pharmacol. 490 2004 127 133
83. A.L. Solomon, K.W. Siddals, P.N. Baker, J.M. Gibson, J.D. Aplin, M. Westwood Placental alkaline phosphatase de-phosphorylates insulin-like growth factor (IGF)-binding protein-1 Placenta 35 2014 520 522
84. R. Deane, A. Sagare, K. Hamm, M. Parisi, B. LaRue, H. Guo, Z. Wu, D.M. Holtzman, B.V. Zlokovic IgG-assisted age-dependent clearance of Alzheimer's amyloid β peptide by the blood-brain barrier neonatal Fc receptor J. Neurosci. 25 2005 11495 11503
85. A.M.S. Hartz, D.S. Miller, B. Bauer Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease Mol. Pharmacol. 77 2010 715 723
86. M.A. Erickson, P.E. Hartvigson, Y. Morofuji, J.B. Owen, D.A. Butterfield, W.A. Banks Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier J. Neuroinflamm. 9 2012 150 10.1186/1742-2094-9-150
87. R. Deane, R.D. Bell, A. Sagare, B.V. Zlokovic Clearance of amyloid-β peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease CNS Neurol. Disord. Drug Targets 8 2009 16 30
88. Y.K. Chuah, R. Basir, H. Talib, T.H. Tie, N. Nordin Receptor for advanced glycation end products and its involvement in inflammatory diseases Int. J. Inflamm. 2013 2013
89. A.P. Sagare, E.A. Winkler, R.D. Bell, R. Deane, B.V. Zlokovic From the liver to the blood-brain barrier: an interconnected system regulating brain amyloid-β levels J. Neurosci. Res. 89 2011 967 968
90. G.D. Silverberg, A.A. Messier, M.C. Miller, J.T. MacHan, S.S. Majmudar, E.G. Stopa, J.E. Donahue, C.E. Johanson Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging J. Neuropathol. Exp. Neurol. 69 2010 1034 1043
91. L.B. Jaeger, S. Dohgu, R. Sultana, J.L. Lynch, J.B. Owen, M.A. Erickson, G.N. Shah, T.O. Price, M.A. Fleegal-Demotta, D.A. Butterfiled, W.A. Banks Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: a mechanism for inflammation in the progression of Alzheimer's disease Brain Behav. Immun. 23 2009 507 517
92. S. Tzaban, R.H. Massol, E. Yen, W. Hamman, S.R. Frank, L.A. Lapierre, S.H. Hansen, J.R. Goldenring, R.S. Blumberg, W.I. Lencer The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity J. Cell Biol. 185 2009 673 684
93. S.M. Claypool, B.L. Dickinson, J.S. Wagner, F. Johansen, N. Venu, J.A. Borawski, W.I. Lencer, R.S. Blumberg Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcγ-receptor Mol. Biol. Cell 15 2004 1746 1759
94. M. Yoshida, S.M. Claypool, J.S. Wagner, E. Mizoguchi, A. Mizoguchi, D.C. Roopenian, W.I. Lencer, R.S. Blumberg Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells Immunity 20 2004 769 783
95. 2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway Mol. Biol. Cell 19 2008 414 423
96. T. Rath, T.T. Kuo, K. Baker, S. Qiao, K. Kobayashi, M. Yoshida, D. Roopenian, E. Fiebiger, W.I. Lencer, R.S. Blumberg The immunologic functions of the neonatal FC receptor for IGG J. Clin. Immunol. 33 2013 S9 S17
97. H.P. Montoyo, C. Vaccaro, M. Hafner, R.J. Ober, W. Mueller, E.S. Ward Conditional deletion of the MHC class l-related receptor FcRn reveals the sites of IgG homeostasis in mice Proc. Natl. Acad. Sci. U.S.A. 106 2009 2788 2793
98. K. Nakata, K. Kobayashi, Y. Ishikawa, M. Yamamoto, Y. Funada, Y. Kotani, R.S. Blumberg, H. Karasuyama, M. Yoshida, Y. Nishimura The transfer of maternal antigen-specific IgG regulates the development of allergic airway inflammation early in life in an FcRn-dependent manner Biochem. Biophys. Res. Commun. 395 2010 238 243
99. G.M. Spiekermann, P.W. Finn, E. Sally Ward, J. Dumont, B.L. Dickinson, R.S. Blumberg, W.I. Lencer Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung J. Exp. Med. 196 2002 303 310
100. Z. Wu, N.E. Simister Tryptophan- and dileucine-based endocytosis signals in the neonatal Fc receptor J. Biol. Chem. 276 2001 5240 5247
101. N.E. Simister, C.M. Story, H. Chen, J.S. Hunt An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta Eur. J. Immunol. 26 1996 1527 1531
102. R.P. Junghans, C.L. Anderson The protection receptor for IgG catabolism is the β2-microglobulin-containing neonatal intestinal transport receptor Proc. Natl. Acad. Sci. U.S.A. 93 1996 5512 5516
103. E.J. Israel, D.F. Wilsker, K.C. Hayes, D. Schoenfeld, N.E. Simister Increased clearance of IgG in mice that lack β2-microglobulin: possible protective role of FcRn Immunology 89 1996 573 578
104. I. Stefaner, A. Stefanescu, W. Hunziker, R. Fuchs Expression of placental alkaline phosphatase does not correlate with IgG binding, internalization and transcytosis Biochem. J. 327 1997 585 592
105. N.A. Goebl, C.M. Babbey, A. Datta-Mannan, D.R. Witcher, V.J. Wroblewski, K.W. Dunn Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells Mol. Biol. Cell 19 2008 5490 5505
106. V. Ghetie, J.G. Hubbard, J. Kim, M. Tsen, Y. Lee, E.S. Ward Abnormally short serum half-lives of IgG in β2-microglobulin-deficient mice Eur. J. Immunol. 26 1996 690 696
107. A.P. Sagare, R.D. Bell, B.V. Zlokovic Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease Cold Spring Harbor Perspect. Med. 2 10 2012 10.1101/cshperspect.a011452 pii: a011452
108. S.J. Henderson, C. Andersson, R. Narwal, J. Janson, T.J. Goldschmidt, P. Appelkvist, A. Bogstedt, A. Steffen, U. Haupts, J. Tebbe, P.O. Freskgård, L. Jermutus, M. Burrell, S.B. Fowler, C.I. Webster Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β Brain 137 2014 553 564
109. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, K.H. Ashe Natural oligomers of the amyloid-β protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84
110. S. Lesné, T.K. Ming, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, K.H. Ashe A specific amyloid-β protein assembly in the brain impairs memory Nature 440 2006 352 357
111. S. Sokolow, K.M. Henkins, T. Bilousova, C.A. Miller, H.V. Vinters, W. Poon, G.M. Cole, K.H. Gylys AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly Neurobiol. Aging 33 2012 1545 1555
112. K. Hocchi, T. Ohashi, T. Miura, K. Sasagawa, Y. Sato, F. Nomura, T. Tomonaga, M. Sunaga, R. Kojima, K. Katayama, T. Kato, T. Sato, T. Komoda, K. Oda Development of an ELISA method for detecting immune complexes between tissue-nonspecific alkaline phosphatase and immunoglobulin G J. Clin. Lab. Anal. 21 2007 322 329
113. R. Makiya, T. Stigbrand Placental alkaline phosphatase as the placental IgG receptor Clin. Chem. 38 1992 2543 2545
114. K. Leitner, I. Ellinger, M. Grill, M. Brabec, R. Fuchs Efficient apical IgG recycling and apical-to-basolateral transcytosis in polarized BeWo cells overexpressing hFcRn Placenta 27 2006 799 811
115. F. Antohe, L. Radulescu, A. Gafencu, V. Ghe, M. Simionescu Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells Hum. Immunol. 62 2001 93 105
116. I. Ellinger, M. Schwab, A. Stefanescu, W. Hunziker, R. Fuchs IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta Eur. J. Immunol. 29 1999 733 744
117. A.W. Vorbrodt, A.S. Lossinsky, H.M. Wisniewski Enzyme cytochemistry of blood-brain barrier (BBB) disturbances Acta Neuropathol. Suppl. 8 1983 43 57
118. H.M. Wisniewski, A.S. Lossinsky, R.C. Moretz, A.W. Vorbrodt, H. Lassmann, R.I. Carp Increased blood-brain barrier permeability in scrapie-infected mice J. Neuropathol. Exp. Neurol. 42 1983 615 626
119. N. Caram-Salas, E. Boileau, G.K. Farrington, E. Garber, E. Brunette, A. Abulrob, D. Stanimirovic In vitro and in vivo methods for assessing fcrn-mediated reverse transcytosis across the blood-brain barrier Methods Mol. Biol. 763 2011 383 401
120. C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, V.H. Perry Systemic inflammation and disease progression in Alzheimer disease Neurology 73 2009 768 774
121. P. May The low-density lipoprotein receptor-related protein 1 in inflammation Curr. Opin. Lipidol. 24 2013 134 137
122. M.S. Kahn, D. Kranjac, C.A. Alonzo, J.H. Haase, R.O. Cedillos, K.A. McLinden, G.W. Boehm, M.J. Chumley Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse Behav. Brain Res. 229 2012 176 184
123. M.K. Weintraub, C.M. Bisson, J.N. Nouri, B.T. Vinson, M.J. Eimerbrink, D. Kranjac, G.W. Boehm, M.J. Chumley Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure Brain Behav. Immun. 33 2013 24 28
124. E. Masliah, M. Mallory, I. Veinbergs, A. Miller, W. Samuel Alterations in apolipoprotein E expression during aging and neurodegeneration Prog. Neurobiol. 50 1996 493 503
125. J.W. Lee, Y.K. Lee, D.Y. Yuk, D.Y. Choi, S.B. Ban, K.W. Oh, J.T. Hong Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation J. Neuroinflamm. 5 2008 37 10.1186/1742-2094-5-37
126. E.D. Roberson, K. Scearce-Levie, J.J. Palop, F. Yan, I.H. Cheng, T. Wu, H. Gerstein, G. Yu, L. Mucke Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model Science 316 2007 750 754
127. C.-X. Gong, T.J. Singh, I. Grundke-Iqbal, K. Iqbal Phosphoprotein phosphatase activities in Alzheimer disease brain J. Neurochem. 61 1993 921 927
128. E.R.L.C. Vardy, K.A.B. Kellett, S.L. Cocklin, N.M. Hooper Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease Neurodegener. Dis. 9 2012 31 37